Standout Papers

Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1... 2011 2026 2016 2021 443
  1. Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG) (2011)
    Ignace Vergote, Elizabeth A. Eisenhauer et al. International Journal of Gynecological Cancer

Immediate Impact

9 by Nobel laureates 29 from Science/Nature 73 standout
Sub-graph 1 of 22

Citing Papers

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
1 intermediate paper

Works of Satoru Sagae being referenced

Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
2011 Standout
Cervical Cancer Working Group Report
2010

Author Peers

Author Last Decade Papers Cites
Satoru Sagae 1298 960 896 75 3.0k
Prafull Ghatage 1240 859 833 108 2.8k
Debra A. Bell 1997 861 660 80 3.2k
Matthew F. Kohler 916 931 798 56 2.5k
Randall K. Gibb 879 1016 590 64 2.6k
Joseph T. Rabban 1178 1060 678 115 3.4k
Nobuyuki Susumu 1122 1286 1099 141 3.0k
Friedrich Kommoss 918 609 784 77 2.5k
Margaret M. Steinhoff 1412 1135 865 77 3.8k
Stefania Cosio 1682 1438 714 117 3.3k
Philippe Moerman 1280 1818 687 124 3.6k

All Works

Loading papers...

Rankless by CCL
2026